NCT04219254 2026-04-15
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
BioInvent International AB
Phase 1/2 Recruiting
BioInvent International AB
Centre Oscar Lambret
DualityBio Inc.
CytomX Therapeutics
Accession Therapeutics Limited
CytomX Therapeutics
BioCytics, Inc.
Akeso
University of Oklahoma
Kumquat Biosciences Inc.
Grit Biotechnology